Professor Cheng Chao, July 14 -- Min of the Institute of Biomedical Engineering at National Tsing Hua University in China has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more efficient use of such critical equipment as respirators.

Developed in collaboration with the Tri-Service General Hospital, the prototype is currently under the clinical validations at a number of medical centers, and Cheng has applied for an emergency use authorization of US Food and Drug Administration.

According to Cheng, the key to prognosis is the cytokine interleukin-6 (IL-6) concentration in the patient's serum; soon after infection with the SARS-CoV-2 , the pers...